In esophageal squamous cell carcinoma, hypermethylation of the MEG3 promoter has been observed, which is related to the downregulation of MEG3, and after treatment with the DNA methyltransferase inhibitor 5-Aza-dC, this process can be reversed (43). The gene discussed is MEG3; the disease is esophageal squamous cell carcinoma.